ERBB2 and neoplasm: Intriguingly, activated CAR-modified PMs by simulating with HER2 overexpressed tumour cells exhibit polarisation toward an anti-tumoral and pro-inflammatory phenotype, meanwhile, promote the proliferation of T cells.